AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer [Yahoo! Finance]
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Yahoo! Finance
Study participants who were enrolled in the NIAGARA study were randomized to receive Imfinzi plus chemotherapy or chemotherapy alone before cystectomy (bladder removal surgery), followed by Imfinzi or no further treatment after surgery. The study achieved statistically significant and clinically meaningful improvement in its primary endpoint of event-free survival (EFS) and the key secondary endpoint of overall survival (OS). Treatment with the Imfinzi-chemotherapy regimen improved survival and reduced the rate at which patients experience disease recurrence or progression. The safety profile of this combination was also safe and well-tolerated by study participants. A type of bladder cancer, MBIC, occurs when cancer cells spread into or through the bladder wall's muscle layer. Management estimates that MBIC accounts for nearly 25% of all bladder cancer cases. Though the current standard of care (SoC) for MBIC patients includes neoadjuvant chemotherapy and radical cystectomy, nea
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- O'Shaughnessy Ventures Awards $100,000 Fellowship Grant to Biotech Entrepreneur Aiming to Revolutionize Microbiome Health Monitoring [Yahoo! Finance]Yahoo! Finance
- Systemic Sclerosis Market to Exhibit Significant Growth by 2034, Predicts DelveInsight | Key Companies - Kyowa Hakko Kirin, AstraZeneca, Mitsubishi Tanabe Pharma, Genentech, Amgen, GlaxoSmithKline, Boehringer Ingelheim [Yahoo! Finance]Yahoo! Finance
- Tanium Wins Coveted Microsoft Independent Software Vendor Innovation Partner of the Year Award [Yahoo! Finance]Yahoo! Finance
- Patritumab Deruxtecan BLA Submission Receives Complete Response Letter from FDA Due to Inspection Findings at Third-Party Manufacturer [Yahoo! Finance]Yahoo! Finance
- Impact and implications of the $35 monthly price cap on asthma inhalers [Yahoo! Finance]Yahoo! Finance
AZN
Sec Filings
- 6/26/24 - Form 11-K
- 6/25/24 - Form 6-K
- 6/25/24 - Form 6-K
- AZN's page on the SEC website